Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Dow Debate: Will Pfizer Crush Merck?
Motley Fool
Monday, February 17, 2014 - 3:23pm
tags:
Pfizer, Merck
Poor Pipeline Management Imperils Lilly's Future Cash Flows
Motley Fool
Monday, February 17, 2014 - 3:22pm
tags:
Eli Lilly, diabetes, insulin, Novo Nordisk, Sanofi, oncology, Alzheimer's disease
Innovation In Huntington's Disease: Auspex Vs. Rivals
Seeking Alpha
Monday, February 17, 2014 - 3:20pm
tags:
Huntington's disease, Auspex Pharmaceuticals, SD-809
Is the Market Discounting Galena’s Acquisition of Mills?
Wall St Cheat Sheet
Monday, February 17, 2014 - 11:13am
tags:
Galena Biopharma, NeuVax, breast cancer, GALE-401
Rx For Software: Can Medidata Solutions Save Drug Companies Billions?
Forbes
Monday, February 17, 2014 - 11:11am
tags:
software, Medidata Solutions
Rumor mill: Apple's working on device to predict heart attacks
Mass Device
Monday, February 17, 2014 - 10:17am
tags:
Apple, heart attacks, devices
Biogen Idec Chairman: New Boss Same as the Old Boss?
Yahoo/24-7 Wall St
Monday, February 17, 2014 - 10:16am
tags:
Biogen Idec, Stelios Papadopoulos
German Proposal to Report Drug Prices Has Roche Concerned
Bloomberg
Monday, February 17, 2014 - 10:15am
tags:
Germany, Roche, drug pricing
Biogen Names Papadopoulos as Its Chairman, Replacing Young
Bloomberg
Monday, February 17, 2014 - 9:14am
tags:
Biogen Idec, Stelios Papadopoulos
Johnson & Johnson: Nothing to Fix Here
TheStreet.com
Monday, February 17, 2014 - 9:11am
tags:
JNJ
Novartis to buy U.S.-based biotech CoStim for undisclosed price
Yahoo/Reuters
Monday, February 17, 2014 - 9:07am
tags:
Novartis, CoStim, M&A
Soros Makes Drugmaker Teva Biggest Stake as Shares Climb
Bloomberg
Sunday, February 16, 2014 - 10:58am
tags:
George Soros, Teva Pharmaceuticals
Teva's leukaemia drug, Synribo receives US FDA approval
Pharmabiz
Sunday, February 16, 2014 - 10:56am
tags:
Teva Pharmaceuticals, leukemia, Synribo
Merck: 7 Different Insiders Have Sold Shares This Month
Seeking Alpha
Sunday, February 16, 2014 - 10:33am
tags:
Merck
Where Will Johnson & Johnson Go Next?
Wall St Cheat Sheet
Sunday, February 16, 2014 - 10:33am
tags:
JNJ
Advaxis's ADXS-HPV Phase 2 Results In Context
Seeking Alpha
Sunday, February 16, 2014 - 10:32am
tags:
Advaxis, ADXS-HPV, cervical cancer
Ignore the Drama: Here’s Why Galena Is a Good Buy
Wall St Cheat Sheet
Sunday, February 16, 2014 - 10:30am
tags:
Galena Biopharma
Merck's Decision To Sell Consumer Division Is Timely And Will Lead To A Higher Stock Price
Seeking Alpha
Saturday, February 15, 2014 - 11:25am
tags:
Merck
Why Novartis Is One of Today's Most Innovative Companies
Motley Fool
Saturday, February 15, 2014 - 11:24am
tags:
Novartis
Amarin Corporation Plc's Rocky Road
Motley Fool
Saturday, February 15, 2014 - 11:23am
tags:
Amarin

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.